NCT07607132

Brief Summary

Two carbohydrate reduced diets, the low FODMAP diet (LFD) and low-carbohydrate diet (LCD), have in randomized controlled studies shown efficacy in relieving symptoms in patients with Irritable Bowel Syndrome (IBS), but access to trained dieticians is limited. Digital delivery may offer a convenient, cost-effective and scalable solution. This pilot study aims to evaluate the effectiveness and feasibility of digitally delivered evidence-based dietary treatments in relieving gastrointestinal, psychological and somatic symptoms and improving quality of life in patients with IBS. Adults with IBS will be recruited via social media and clinical referrals and will receive their choice of the two dietary treatments: LFD with traditional IBS dietary advice or LCD. Participants will get access to the digital platform which contains information about the study, IBS pathophysiology, the treatment diet along with recipes and a mobile application for food scanning. Participants will complete digital questionnaires at baseline and week four to evaluate changes in gastrointestinal symptoms (IBS-SSS), somatic and psychological symptoms (PHQ-15, HADS, VSI) and quality of life (IBS-QoL). Feasibility and adherence is assessed with an evaluation questionnaire.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 2, 2024

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2025

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

May 19, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 26, 2026

Completed
Last Updated

May 28, 2026

Status Verified

May 1, 2026

Enrollment Period

11 months

First QC Date

May 19, 2026

Last Update Submit

May 25, 2026

Conditions

Keywords

IBSdietary treatmentdigital

Outcome Measures

Primary Outcomes (1)

  • Proportion of patients with significant gastrointestinal symtom reduction

    A responder to treatment is defined as having a symptom reduction \> 50 measured by IBS-SSS

    From baseline vs 4 weeks after starting digital dietary treatment.

Study Arms (1)

Digital delivery of low FODMAP diet or low-carbohydrate diet

OTHER
Other: Digital dietary platform

Interventions

a digital platform with information about the study, IBS, the treatment diet along with recipes and a mobile application for food scanning.

Digital delivery of low FODMAP diet or low-carbohydrate diet

Eligibility Criteria

Age18 Years - 64 Years
Sexall(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Diagnosed with IBS (Rome IV) by physician
  • Age 18-64
  • Ability to read and understand Swedish
  • Signed informed consent

You may not qualify if:

  • Received dietary treatmen for IBS previously
  • Manifestations of other conditions that may explain gastrointestinal symptoms
  • Manifestation of other serious medical conditions
  • Patients with ongoing eating disorders
  • Pregnant/lactating women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dept of Internal Medicine, Sahlgrenska University Hospital

Gothenburg, 41345, Sweden

Location

MeSH Terms

Conditions

Irritable Bowel Syndrome

Condition Hierarchy (Ancestors)

Colonic Diseases, FunctionalColonic DiseasesIntestinal DiseasesGastrointestinal DiseasesDigestive System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Effect of digital dietary treatment with either of the two treatments diets. Participants choose from the two diets.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

May 19, 2026

First Posted

May 26, 2026

Study Start

May 2, 2024

Primary Completion

April 1, 2025

Study Completion

April 1, 2025

Last Updated

May 28, 2026

Record last verified: 2026-05

Locations